Colony Stimulating Factor 1 Receptor (CSF1R) As a Potential Novel Therapeutic Target in CLL

被引:0
|
作者
Sweeney, Tyler [1 ]
Spurgeon, Stephen E. [2 ]
Tyner, Jeffrey W. [3 ]
Agarwal, Anupriya [4 ]
Ho, Hibery [1 ]
Traer, Elie [4 ]
Lee, Patrice [5 ]
Chantry, David [5 ]
Druker, Brian J. [4 ]
Loriaux, Marc [4 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Ctr Hematol Malignancies, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA
[5] Array Biopharma, Boulder, CO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival
    Cheng, Baoying
    Li, Xin
    Dai, Kai
    Duan, Shengshun
    Rong, Zhouyi
    Chen, Yingmin
    Lu, Liangcheng
    Liu, Zhaoji
    Huang, Xiaohua
    Xu, Huaxi
    Zhang, Yun-Wu
    Zheng, Honghua
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] SYHA1813, a vascular endothelial growth factor receptor (VEGFR) 1-3/colony-stimulating factor 1 receptor (CSF1R) inhibitor, in patients with recurrent glioblastoma
    Li, W.
    Kang, Z.
    Chen, F.
    Li, S.
    Zhang, B.
    Huang, M.
    Yang, X.
    She, F.
    Xiang, S.
    Liu, G.
    Liu, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S408 - S408
  • [33] CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple
    Hume, David A.
    Batoon, Lena
    Sehgal, Anuj
    Keshvari, Sahar
    Irvine, Katharine M.
    CURRENT OSTEOPOROSIS REPORTS, 2022, 20 (6) : 516 - 531
  • [34] CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple
    David A. Hume
    Lena Batoon
    Anuj Sehgal
    Sahar Keshvari
    Katharine M. Irvine
    Current Osteoporosis Reports, 2022, 20 : 516 - 531
  • [35] Cloning and expression of porcine Colony Stimulating Factor-1 (CSF-1) and Colony Stimulating Factor-1 Receptor (CSF-1R) and analysis of the species specificity of stimulation by CSF-1 and Interleukin 34
    Gow, Deborah J.
    Garceau, Valerie
    Kapetanovic, Ronan
    Sester, David P.
    Fici, Greg J.
    Shelly, John A.
    Wilson, Thomas L.
    Hume, David A.
    CYTOKINE, 2012, 60 (03) : 793 - 805
  • [36] Expression of colony stimulating factor-1 receptor (CSF-1R) by CNS neurons in mice
    Wang, YQ
    Berezovska, O
    Fedoroff, S
    JOURNAL OF NEUROSCIENCE RESEARCH, 1999, 57 (05) : 616 - 632
  • [37] A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers
    Bendell, Johanna C.
    Tolcher, Anthony W.
    Jones, Suzanne F.
    Beeram, Muralidhar
    Infante, Jeffrey R.
    Larsen, Paul
    Rasor, Kevin
    Garrus, Jennifer E.
    Li, Jinfang
    Cable, P. Louann
    Eberhardt, Christine
    Schreiber, Jennifer
    Rush, Selena
    Wood, Kenneth W.
    Barret, Emma
    Patnaik, Amita
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [38] Role of the Colony-Stimulator Factor-1 Receptor (CSF1R) T-cell Lymphoma Progression
    Murga-Zamalloa, Carlos
    Polka, Avery
    Brown, Noah
    Bailey, Nathaniel
    Wilcox, Ryan
    MODERN PATHOLOGY, 2017, 30 : 364A - 364A
  • [39] A pilot study of PLX3397, a selective colony-stimulating factor 1 receptor (CSF1R) kinase inhibitor, in pigmented villonodular synovitis (PVNS).
    Tap, William D.
    Anthony, Stephen Patrick
    Chmielowski, Bartosz
    Staddon, Arthur P.
    Cohn, Allen Lee
    Shapiro, Geoffrey
    Puzanov, Igor
    Kwak, Eunice L.
    Wagner, Andrew J.
    Peterfy, Charles
    Hsu, Henry H.
    Gee, Carolyn
    Lin, Paul S.
    Tong, Sandra
    Wainberg, Zev A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Role of the Colony-Stimulator Factor-1 Receptor (CSF1R) T-cell Lymphoma Progression
    Murga-Zamalloa, Carlos
    Polka, Avety
    Brown, Noah
    Bailey, Nathaniel
    Wilcox, Ryan
    LABORATORY INVESTIGATION, 2017, 97 : 364A - 364A